A Randomized Crossover Trial of a Pressure Relief Technology (SensAwake™) in Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea.

Sleep Disord · 2017 · PMC5749294 · PMID 29410921

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

This post hoc analysis showed a trend towards an increase in the average number of minutes on days of CPAP use with SensAwake in the initial four weeks on their first treatment with SensAwake ON ( n = 18) compared to SensAwake OFF ( n = 12), which did not reach statistical significance (SensAwake ON 322.89 ± 26.46 versus SensAwake OFF 282.25 ± 30.58).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.